Hybridoma technology involves fusion of:
Hybridoma formation relies on merging two complementary cellular programs within one cytoplasm to create self-renewing antibody factory. Splenic B lymphocytes from immunized donor possess productively rearranged heavy chain locus on chromosome 14 with VDJ recombination mediated by RAG1/2 and light chain kappa or lambda locus with VJ recombination, encoding high-affinity combining site selected through germinal center affinity maturation involving activation-induced deaminase, but they senesce within days after extraction due to lack of telomerase, dependence on BAFF survival signal, and activa
Ref: Janeway Immunobiology 9th ed monoclonal generation; J Genet Eng Biotechnol 2020 PMC7414427 hybridoma fusion B myeloma.